-
1
-
-
34249064632
-
Epstein-Barr virus-associated malignancies of the immunocompromised host
-
Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), 5th ed, Lippincott Williams & Wilkins, Philadelphia, PA
-
Rickinson AB, Kieff E. 2007. Epstein-Barr virus-associated malignancies of the immunocompromised host, p 2668-2700. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed, vol 2. Lippincott Williams & Wilkins, Philadelphia, PA.
-
(2007)
Fields virology
, vol.2
, pp. 2668-2700
-
-
Rickinson, A.B.1
Kieff, E.2
-
2
-
-
56349158720
-
The curious case of the tumour virus: 50 years of Burkitt's lymphoma
-
Thorley-Lawson DA, Allday MJ. 2008. The curious case of the tumour virus: 50 years of Burkitt's lymphoma. Nat Rev Microbiol 6:913-924. http://dx.doi.org/10.1038/nrmicro2015.
-
(2008)
Nat Rev Microbiol
, vol.6
, pp. 913-924
-
-
Thorley-Lawson, D.A.1
Allday, M.J.2
-
3
-
-
2442679371
-
Steps involved in immortalization and tumorigenesis in human B-lymphoblastoid cell lines transformed by Epstein-Barr virus
-
Sugimoto M, Tahara H, Ide T, Furuichi Y. 2004. Steps involved in immortalization and tumorigenesis in human B-lymphoblastoid cell lines transformed by Epstein-Barr virus. Cancer Res 64:3361-3364. http://dx.doi.org/10.1158/0008-5472.CAN-04-0079.
-
(2004)
Cancer Res
, vol.64
, pp. 3361-3364
-
-
Sugimoto, M.1
Tahara, H.2
Ide, T.3
Furuichi, Y.4
-
4
-
-
37549015263
-
Germinal centres: role in B-cell physiology and malignancy
-
Klein U, Dalla-Favera R. 2008. Germinal centres: role in B-cell physiology and malignancy. Nat Rev Immunol 8:22-33. http://dx.doi.org/10.1038/nri2217.
-
(2008)
Nat Rev Immunol
, vol.8
, pp. 22-33
-
-
Klein, U.1
Dalla-Favera, R.2
-
5
-
-
0036884169
-
Lymphoid malignancies: the dark side of B-cell differentiation
-
Shaffer AL, Rosenwald A, Staudt LM. 2002. Lymphoid malignancies: the dark side of B-cell differentiation. Nat Rev Immunol 2:920-932. http://dx.doi.org/10.1038/nri953.
-
(2002)
Nat Rev Immunol
, vol.2
, pp. 920-932
-
-
Shaffer, A.L.1
Rosenwald, A.2
Staudt, L.M.3
-
6
-
-
0035496101
-
Epstein-Barr virus: exploiting the immune system
-
Thorley-Lawson DA. 2001. Epstein-Barr virus: exploiting the immune system. Nat Rev Immunol 1:75-82. http://dx.doi.org/10.1038/35095584.
-
(2001)
Nat Rev Immunol
, vol.1
, pp. 75-82
-
-
Thorley-Lawson, D.A.1
-
7
-
-
35348905543
-
Epstein-Barr virus exploits BSAP/Pax5 to achieve the B-cell specificity of its growthtransforming program
-
Tierney R, Nagra J, Hutchings I, Shannon-Lowe C, Altmann M, Hammerschmidt W, Rickinson A, Bell A. 2007. Epstein-Barr virus exploits BSAP/Pax5 to achieve the B-cell specificity of its growthtransforming program. J Virol 81:10092-10100. http://dx.doi.org/10.1128/JVI.00358-07.
-
(2007)
J Virol
, vol.81
, pp. 10092-10100
-
-
Tierney, R.1
Nagra, J.2
Hutchings, I.3
Shannon-Lowe, C.4
Altmann, M.5
Hammerschmidt, W.6
Rickinson, A.7
Bell, A.8
-
8
-
-
0028133036
-
Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signalbinding protein J kappa
-
Henkel T, Ling PD, Hayward SD, Peterson MG. 1994. Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signalbinding protein J kappa. Science 265:92-95. http://dx.doi.org/10.1126/science.8016657.
-
(1994)
Science
, vol.265
, pp. 92-95
-
-
Henkel, T.1
Ling, P.D.2
Hayward, S.D.3
Peterson, M.G.4
-
9
-
-
0028924018
-
Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1
-
Johannsen E, Koh E, Mosialos G, Tong X, Kieff E, Grossman SR. 1995. Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1. J Virol 69:253-262.
-
(1995)
J Virol
, vol.69
, pp. 253-262
-
-
Johannsen, E.1
Koh, E.2
Mosialos, G.3
Tong, X.4
Kieff, E.5
Grossman, S.R.6
-
10
-
-
77649188072
-
Cellular factors associated with latency and spontaneous Epstein-Barr virus reactivation in B-lymphoblastoid cell lines
-
Davies ML, Xu S, Lyons-Weiler J, Rosendorff A, Webber SA, Wasil LR, Metes D, Rowe DT. 2010. Cellular factors associated with latency and spontaneous Epstein-Barr virus reactivation in B-lymphoblastoid cell lines. Virology 400:53-67. http://dx.doi.org/10.1016/j.virol.2010.01.002.
-
(2010)
Virology
, vol.400
, pp. 53-67
-
-
Davies, M.L.1
Xu, S.2
Lyons-Weiler, J.3
Rosendorff, A.4
Webber, S.A.5
Wasil, L.R.6
Metes, D.7
Rowe, D.T.8
-
11
-
-
73849116103
-
Upregulation of STAT3 marks Burkitt lymphoma cells refractory to Epstein-Barr virus lytic cycle induction by HDAC inhibitors
-
Daigle D, Megyola C, El-Guindy A, Gradoville L, Tuck D, Miller G, Bhaduri-McIntosh S. 2010. Upregulation of STAT3 marks Burkitt lymphoma cells refractory to Epstein-Barr virus lytic cycle induction by HDAC inhibitors. J Virol 84:993-1004. http://dx.doi.org/10.1128/JVI.01745-09.
-
(2010)
J Virol
, vol.84
, pp. 993-1004
-
-
Daigle, D.1
Megyola, C.2
El-Guindy, A.3
Gradoville, L.4
Tuck, D.5
Miller, G.6
Bhaduri-McIntosh, S.7
-
12
-
-
84860904972
-
The B-cell specific transcription factor, Oct-2, promotes Epstein-Barr virus latency by inhibiting the viral immediate-early protein, BZLF1
-
Robinson AR, Kwek SS, Kenney SC. 2012. The B-cell specific transcription factor, Oct-2, promotes Epstein-Barr virus latency by inhibiting the viral immediate-early protein, BZLF1. PLoS Pathog 8:e1002516. http://dx.doi.org/10.1371/journal.ppat.1002516.
-
(2012)
PLoS Pathog
, vol.8
-
-
Robinson, A.R.1
Kwek, S.S.2
Kenney, S.C.3
-
13
-
-
73549083897
-
Gammaherpesvirus-driven plasma cell differentiation regulates virus reactivation from latently infected B lymphocytes
-
Liang X, Collins CM, Mendel JB, Iwakoshi NN, Speck SH. 2009. Gammaherpesvirus-driven plasma cell differentiation regulates virus reactivation from latently infected B lymphocytes. PLoS Pathog 5:e1000677. http://dx.doi.org/10.1371/journal.ppat.1000677.
-
(2009)
PLoS Pathog
, vol.5
-
-
Liang, X.1
Collins, C.M.2
Mendel, J.B.3
Iwakoshi, N.N.4
Speck, S.H.5
-
14
-
-
37049001249
-
Plasma cell-specific transcription factor XBP-1s binds to and transactivates the Epstein-Barr virus BZLF1 promoter
-
Sun CC, Thorley-Lawson DA. 2007. Plasma cell-specific transcription factor XBP-1s binds to and transactivates the Epstein-Barr virus BZLF1 promoter. J Virol 81:13566-13577. http://dx.doi.org/10.1128/JVI.01055-07.
-
(2007)
J Virol
, vol.81
, pp. 13566-13577
-
-
Sun, C.C.1
Thorley-Lawson, D.A.2
-
15
-
-
4944266319
-
Epstein-Barr virus: 40 years on
-
Young LS, Rickinson AB. 2004. Epstein-Barr virus: 40 years on. Nat Rev Cancer 4:757-768. http://dx.doi.org/10.1038/nrc1452.
-
(2004)
Nat Rev Cancer
, vol.4
, pp. 757-768
-
-
Young, L.S.1
Rickinson, A.B.2
-
16
-
-
0041422143
-
Epstein-Barr virus latent membrane protein 1: structure and functions
-
Li HP, Chang YS. 2003. Epstein-Barr virus latent membrane protein 1: structure and functions. J Biomed Sci 10:490-504. http://dx.doi.org/10.1007/BF02256110.
-
(2003)
J Biomed Sci
, vol.10
, pp. 490-504
-
-
Li, H.P.1
Chang, Y.S.2
-
17
-
-
84863123337
-
Immune surveillance and therapy of lymphomas driven by Epstein-Barr virus protein LMP1 in a mouse model
-
Zhang B, Kracker S, Yasuda T, Casola S, Vanneman M, Homig-Holzel C, Wang Z, Derudder E, Li S, Chakraborty T, Cotter SE, Koyama S, Currie T, Freeman GJ, Kutok JL, Rodig SJ, Dranoff G, Rajewsky K. 2012. Immune surveillance and therapy of lymphomas driven by Epstein-Barr virus protein LMP1 in a mouse model. Cell 148:739-751. http://dx.doi.org/10.1016/j.cell.2011.12.031.
-
(2012)
Cell
, vol.148
, pp. 739-751
-
-
Zhang, B.1
Kracker, S.2
Yasuda, T.3
Casola, S.4
Vanneman, M.5
Homig-Holzel, C.6
Wang, Z.7
Derudder, E.8
Li, S.9
Chakraborty, T.10
Cotter, S.E.11
Koyama, S.12
Currie, T.13
Freeman, G.J.14
Kutok, J.L.15
Rodig, S.J.16
Dranoff, G.17
Rajewsky, K.18
-
18
-
-
33745506986
-
Unexpected structure of Epstein-Barr virus lytic cycle activator Zta
-
Sinclair AJ. 2006. Unexpected structure of Epstein-Barr virus lytic cycle activator Zta. Trends Microbiol 14:289-291. http://dx.doi.org/10.1016/j.tim.2006.05.003.
-
(2006)
Trends Microbiol
, vol.14
, pp. 289-291
-
-
Sinclair, A.J.1
-
19
-
-
67651015678
-
EBV Zta protein induces the expression of interleukin-13, promoting the proliferation of EBV-infected B cells and lymphoblastoid cell lines
-
Tsai SC, Lin SJ, Chen PW, Luo WY, Yeh TH, Wang HW, Chen CJ, Tsai CH. 2009. EBV Zta protein induces the expression of interleukin-13, promoting the proliferation of EBV-infected B cells and lymphoblastoid cell lines. Blood 114:109-118. http://dx.doi.org/10.1182/blood-2008-12-193375.
-
(2009)
Blood
, vol.114
, pp. 109-118
-
-
Tsai, S.C.1
Lin, S.J.2
Chen, P.W.3
Luo, W.Y.4
Yeh, T.H.5
Wang, H.W.6
Chen, C.J.7
Tsai, C.H.8
-
20
-
-
84887997018
-
Keeping it quiet: chromatin control of gammaherpesvirus latency
-
Lieberman PM. 2013. Keeping it quiet: chromatin control of gammaherpesvirus latency. Nat Rev Microbiol 11:863-875. http://dx.doi.org/10.1038/nrmicro3135.
-
(2013)
Nat Rev Microbiol
, vol.11
, pp. 863-875
-
-
Lieberman, P.M.1
-
21
-
-
79953048485
-
Pathogenesis and host control of gammaherpesviruses: lessons from the mouse
-
Barton E, Mandal P, Speck SH. 2011. Pathogenesis and host control of gammaherpesviruses: lessons from the mouse. Annu Rev Immunol 29: 351-397. http://dx.doi.org/10.1146/annurev-immunol-072710-081639.
-
(2011)
Annu Rev Immunol
, vol.29
, pp. 351-397
-
-
Barton, E.1
Mandal, P.2
Speck, S.H.3
-
22
-
-
33644765841
-
IL-32, a proinflammatory cytokine in rheumatoid arthritis
-
Joosten LA, Netea MG, Kim SH, Yoon DY, Oppers-Walgreen B, Radstake TR, Barrera P, van de Loo FA, Dinarello CA, van den Berg WB. 2006. IL-32, a proinflammatory cytokine in rheumatoid arthritis. Proc Natl Acad Sci U S A 103:3298-3303. http://dx.doi.org/10.1073/pnas.0511233103.
-
(2006)
Proc Natl Acad Sci U S A
, vol.103
, pp. 3298-3303
-
-
Joosten, L.A.1
Netea, M.G.2
Kim, S.H.3
Yoon, D.Y.4
Oppers-Walgreen, B.5
Radstake, T.R.6
Barrera, P.7
van de Loo, F.A.8
Dinarello, C.A.9
van den Berg, W.B.10
-
23
-
-
33750299010
-
IL-32, a novel cytokine with a possible role in disease
-
Dinarello CA, Kim SH. 2006. IL-32, a novel cytokine with a possible role in disease. Ann Rheum Dis 65(Suppl 3):iii61-iii64. http://dx.doi.org/10.1136/ard.2006.058511.
-
(2006)
Ann Rheum Dis
, vol.65
, pp. iii61-iii64
-
-
Dinarello, C.A.1
Kim, S.H.2
-
24
-
-
12444304581
-
Interleukin-32: a cytokine and inducer of TNFalpha
-
Kim SH, Han SY, Azam T, Yoon DY, Dinarello CA. 2005. Interleukin-32: a cytokine and inducer of TNFalpha. Immunity 22:131-142. http://dx.doi.org/10.1016/j.immuni.2004.12.003.
-
(2005)
Immunity
, vol.22
, pp. 131-142
-
-
Kim, S.H.1
Han, S.Y.2
Azam, T.3
Yoon, D.Y.4
Dinarello, C.A.5
-
25
-
-
31544432072
-
Involvement of IL-32 in activation-induced cell death in T cells
-
Goda C, Kanaji T, Kanaji S, Tanaka G, Arima K, Ohno S, Izuhara K. 2006. Involvement of IL-32 in activation-induced cell death in T cells. Int Immunol 18:233-240. http://dx.doi.org/10.1093/intimm/dxh339.
-
(2006)
Int Immunol
, vol.18
, pp. 233-240
-
-
Goda, C.1
Kanaji, T.2
Kanaji, S.3
Tanaka, G.4
Arima, K.5
Ohno, S.6
Izuhara, K.7
-
26
-
-
73849136741
-
Suppressing IL-32 in monocytes impairs the induction of the proinflammatory cytokines TNFalpha and IL-1beta
-
Hong J, Bae S, Kang Y, Yoon D, Bai X, Chan ED, Azam T, Dinarello CA, Lee S, Her E, Rho G, Kim S. 2010. Suppressing IL-32 in monocytes impairs the induction of the proinflammatory cytokines TNFalpha and IL-1beta. Cytokine 49:171-176. http://dx.doi.org/10.1016/j.cyto.2009.10.003.
-
(2010)
Cytokine
, vol.49
, pp. 171-176
-
-
Hong, J.1
Bae, S.2
Kang, Y.3
Yoon, D.4
Bai, X.5
Chan, E.D.6
Azam, T.7
Dinarello, C.A.8
Lee, S.9
Her, E.10
Rho, G.11
Kim, S.12
-
27
-
-
62649165849
-
IL-32-dependent effects of IL-1beta on endothelial cell functions
-
Nold-Petry CA, Nold MF, Zepp JA, Kim SH, Voelkel NF, Dinarello CA. 2009. IL-32-dependent effects of IL-1beta on endothelial cell functions. Proc Natl Acad Sci U S A 106:3883-3888. http://dx.doi.org/10.1073/pnas.0813334106.
-
(2009)
Proc Natl Acad Sci U S A
, vol.106
, pp. 3883-3888
-
-
Nold-Petry, C.A.1
Nold, M.F.2
Zepp, J.A.3
Kim, S.H.4
Voelkel, N.F.5
Dinarello, C.A.6
-
28
-
-
84867426764
-
Intracellular interaction of interleukin (IL)-32alpha with protein kinase Cepsilon (PKCepsilon) and STAT3 protein augments IL-6 production in THP-1 promonocytic cells
-
Kang JW, Park YS, Lee DH, Kim JH, Kim MS, Bak Y, Hong J, Yoon DY. 2012. Intracellular interaction of interleukin (IL)-32alpha with protein kinase Cepsilon (PKCepsilon) and STAT3 protein augments IL-6 production in THP-1 promonocytic cells. J Biol Chem 287:35556-35564. http://dx.doi.org/10.1074/jbc.M112.400911.
-
(2012)
J Biol Chem
, vol.287
, pp. 35556-35564
-
-
Kang, J.W.1
Park, Y.S.2
Lee, D.H.3
Kim, J.H.4
Kim, M.S.5
Bak, Y.6
Hong, J.7
Yoon, D.Y.8
-
29
-
-
33644755536
-
Proteinase 3 is an IL-32 binding protein
-
Novick D, Rubinstein M, Azam T, Rabinkov A, Dinarello CA, Kim SH. 2006. Proteinase 3 is an IL-32 binding protein. Proc Natl Acad Sci U S A 103:3316-3321. http://dx.doi.org/10.1073/pnas.0511206103.
-
(2006)
Proc Natl Acad Sci U S A
, vol.103
, pp. 3316-3321
-
-
Novick, D.1
Rubinstein, M.2
Azam, T.3
Rabinkov, A.4
Dinarello, C.A.5
Kim, S.H.6
-
30
-
-
34547887644
-
Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease
-
Shioya M, Nishida A, Yagi Y, Ogawa A, Tsujikawa T, Kim-Mitsuyama S, Takayanagi A, Shimizu N, Fujiyama Y, Andoh A. 2007. Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease. Clin Exp Immunol 149:480-486. http://dx.doi.org/10.1111/j.1365-2249.2007.03439.x.
-
(2007)
Clin Exp Immunol
, vol.149
, pp. 480-486
-
-
Shioya, M.1
Nishida, A.2
Yagi, Y.3
Ogawa, A.4
Tsujikawa, T.5
Kim-Mitsuyama, S.6
Takayanagi, A.7
Shimizu, N.8
Fujiyama, Y.9
Andoh, A.10
-
31
-
-
55549144018
-
IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease
-
Calabrese F, Baraldo S, Bazzan E, Lunardi F, Rea F, Maestrelli P, Turato G, Lokar-Oliani K, Papi A, Zuin R, Sfriso P, Balestro E, Dinarello CA, Saetta M. 2008. IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 178:894-901. http://dx.doi.org/10.1164/rccm.200804-646OC.
-
(2008)
Am J Respir Crit Care Med
, vol.178
, pp. 894-901
-
-
Calabrese, F.1
Baraldo, S.2
Bazzan, E.3
Lunardi, F.4
Rea, F.5
Maestrelli, P.6
Turato, G.7
Lokar-Oliani, K.8
Papi, A.9
Zuin, R.10
Sfriso, P.11
Balestro, E.12
Dinarello, C.A.13
Saetta, M.14
-
32
-
-
41349093520
-
Interleukin-32 monoclonal antibodies for immunohistochemistry, Western blotting, and ELISA
-
Kim KH, Shim JH, Seo EH, Cho MC, Kang JW, Kim SH, Yu DY, Song EY, Lee HG, Sohn JH, Kim J, Dinarello CA, Yoon DY. 2008. Interleukin-32 monoclonal antibodies for immunohistochemistry, Western blotting, and ELISA. J Immunol Methods 333:38-50. http://dx.doi.org/10.1016/j.jim.2007.12.017.
-
(2008)
J Immunol Methods
, vol.333
, pp. 38-50
-
-
Kim, K.H.1
Shim, J.H.2
Seo, E.H.3
Cho, M.C.4
Kang, J.W.5
Kim, S.H.6
Yu, D.Y.7
Song, E.Y.8
Lee, H.G.9
Sohn, J.H.10
Kim, J.11
Dinarello, C.A.12
Yoon, D.Y.13
-
33
-
-
70349878484
-
Expression of IL-32 in human lung cancer is related to the histotype and metastatic phenotype
-
Sorrentino C, Di Carlo E. 2009. Expression of IL-32 in human lung cancer is related to the histotype and metastatic phenotype. Am J Respir Crit Care Med 180:769-779. http://dx.doi.org/10.1164/rccm.200903-0400OC.
-
(2009)
Am J Respir Crit Care Med
, vol.180
, pp. 769-779
-
-
Sorrentino, C.1
Di Carlo, E.2
-
34
-
-
67650522875
-
Interleukin-32 expression in the pancreas
-
Nishida A, Andoh A, Inatomi O, Fujiyama Y. 2009. Interleukin-32 expression in the pancreas. J Biol Chem 284:17868-17876. http://dx.doi.org/10.1074/jbc.M900368200.
-
(2009)
J Biol Chem
, vol.284
, pp. 17868-17876
-
-
Nishida, A.1
Andoh, A.2
Inatomi, O.3
Fujiyama, Y.4
-
35
-
-
84857267860
-
Interleukin 32 (IL-32) contains a typical alpha-helix bundle structure that resembles focal adhesion targeting region of focal adhesion kinase-1
-
Heinhuis B, Koenders MI, van den Berg WB, Netea MG, Dinarello CA, Joosten LA. 2012. Interleukin 32 (IL-32) contains a typical alpha-helix bundle structure that resembles focal adhesion targeting region of focal adhesion kinase-1. J Biol Chem 287:5733-5743. http://dx.doi.org/10.1074/jbc.M111.288290.
-
(2012)
J Biol Chem
, vol.287
, pp. 5733-5743
-
-
Heinhuis, B.1
Koenders, M.I.2
van den Berg, W.B.3
Netea, M.G.4
Dinarello, C.A.5
Joosten, L.A.6
-
36
-
-
80051554138
-
Requirement for LMP1-induced RON receptor tyrosine kinase in Epstein-Barr virus-mediated B-cell proliferation
-
Chou YC, Lin SJ, Lu J, Yeh TH, Chen CL, Weng PL, Lin JH, Yao M, Tsai CH. 2011. Requirement for LMP1-induced RON receptor tyrosine kinase in Epstein-Barr virus-mediated B-cell proliferation. Blood 118: 1340-1349. http://dx.doi.org/10.1182/blood-2011-02-335448.
-
(2011)
Blood
, vol.118
, pp. 1340-1349
-
-
Chou, Y.C.1
Lin, S.J.2
Lu, J.3
Yeh, T.H.4
Chen, C.L.5
Weng, P.L.6
Lin, J.H.7
Yao, M.8
Tsai, C.H.9
-
37
-
-
84881219446
-
Autocrine CCL3 and CCL4 induced by the oncoprotein LMP1 promote Epstein-Barr virustriggered B cell proliferation
-
Tsai SC, Lin SJ, Lin CJ, Chou YC, Lin JH, Yeh TH, Chen MR, Huang LM, Lu MY, Huang YC, Chen HY, Tsai CH. 2013. Autocrine CCL3 and CCL4 induced by the oncoprotein LMP1 promote Epstein-Barr virustriggered B cell proliferation. J Virol 87:9041-9052. http://dx.doi.org/10.1128/JVI.00541-13.
-
(2013)
J Virol
, vol.87
, pp. 9041-9052
-
-
Tsai, S.C.1
Lin, S.J.2
Lin, C.J.3
Chou, Y.C.4
Lin, J.H.5
Yeh, T.H.6
Chen, M.R.7
Huang, L.M.8
Lu, M.Y.9
Huang, Y.C.10
Chen, H.Y.11
Tsai, C.H.12
-
38
-
-
79551699531
-
Interplay between PKCdelta and Sp1 on histone deacetylase inhibitormediated Epstein-Barr virus reactivation
-
Tsai PF, Lin SJ, Weng PL, Tsai SC, Lin JH, Chou YC, Tsai CH. 2011. Interplay between PKCdelta and Sp1 on histone deacetylase inhibitormediated Epstein-Barr virus reactivation. J Virol 85:2373-2385. http://dx.doi.org/10.1128/JVI.01602-10.
-
(2011)
J Virol
, vol.85
, pp. 2373-2385
-
-
Tsai, P.F.1
Lin, S.J.2
Weng, P.L.3
Tsai, S.C.4
Lin, J.H.5
Chou, Y.C.6
Tsai, C.H.7
-
39
-
-
28044472990
-
Detection of Epstein-Barr virus BGLF4 protein kinase in virus replication compartments and virus particles
-
Wang JT, Yang PW, Lee CP, Han CH, Tsai CH, Chen MR. 2005. Detection of Epstein-Barr virus BGLF4 protein kinase in virus replication compartments and virus particles. J Gen Virol 86:3215-3225. http://dx.doi.org/10.1099/vir.0.81313-0.
-
(2005)
J Gen Virol
, vol.86
, pp. 3215-3225
-
-
Wang, J.T.1
Yang, P.W.2
Lee, C.P.3
Han, C.H.4
Tsai, C.H.5
Chen, M.R.6
-
40
-
-
0036721207
-
Epstein-Barr virus latent membrane protein 2A regulates c-Jun protein through extracellular signal-regulated kinase
-
Chen SY, Lu J, Shih YC, Tsai CH. 2002. Epstein-Barr virus latent membrane protein 2A regulates c-Jun protein through extracellular signal-regulated kinase. J Virol 76:9556-9561. http://dx.doi.org/10.1128/JVI.76.18.9556-9561.2002.
-
(2002)
J Virol
, vol.76
, pp. 9556-9561
-
-
Chen, S.Y.1
Lu, J.2
Shih, Y.C.3
Tsai, C.H.4
-
41
-
-
8644230153
-
Induction of Epstein-Barr virus latent membrane protein 1 by a lytic transactivator Rta
-
Chang Y, Lee HH, Chang SS, Hsu TY, Wang PW, Chang YS, Takada K, Tsai CH. 2004. Induction of Epstein-Barr virus latent membrane protein 1 by a lytic transactivator Rta. J Virol 78:13028-13036. http://dx.doi.org/10.1128/JVI.78.23.13028-13036.2004.
-
(2004)
J Virol
, vol.78
, pp. 13028-13036
-
-
Chang, Y.1
Lee, H.H.2
Chang, S.S.3
Hsu, T.Y.4
Wang, P.W.5
Chang, Y.S.6
Takada, K.7
Tsai, C.H.8
-
42
-
-
0026503847
-
Identification of a novel gene expressed in activated natural killer cells and T cells
-
Dahl CA, Schall RP, He HL, Cairns JS. 1992. Identification of a novel gene expressed in activated natural killer cells and T cells. J Immunol 148:597-603.
-
(1992)
J Immunol
, vol.148
, pp. 597-603
-
-
Dahl, C.A.1
Schall, R.P.2
He, H.L.3
Cairns, J.S.4
-
43
-
-
70350510213
-
Interactions between IL-32 and tumor necrosis factor alpha contribute to the exacerbation of immune-inflammatory diseases
-
Shoda H, Fujio K, Yamaguchi Y, Okamoto A, Sawada T, Kochi Y, Yamamoto K. 2006. Interactions between IL-32 and tumor necrosis factor alpha contribute to the exacerbation of immune-inflammatory diseases. Arthritis Res Ther 8:R166. http://dx.doi.org/10.1186/ar2074.
-
(2006)
Arthritis Res Ther
, vol.8
, pp. R166
-
-
Shoda, H.1
Fujio, K.2
Yamaguchi, Y.3
Okamoto, A.4
Sawada, T.5
Kochi, Y.6
Yamamoto, K.7
-
44
-
-
77953512038
-
Epstein-Barr virus in Burkitt's lymphoma: a role for latent membrane protein 2A
-
Bieging KT, Swanson-Mungerson M, Amick AC, Longnecker R. 2010. Epstein-Barr virus in Burkitt's lymphoma: a role for latent membrane protein 2A. Cell Cycle 9:901-908. http://dx.doi.org/10.4161/cc.9.5.10840.
-
(2010)
Cell Cycle
, vol.9
, pp. 901-908
-
-
Bieging, K.T.1
Swanson-Mungerson, M.2
Amick, A.C.3
Longnecker, R.4
-
45
-
-
70349210826
-
Role of the Epstein-Barr virus-encoded latent membrane protein-1, LMP1, in the pathogenesis of nasopharyngeal carcinoma
-
Morris MA, Dawson CW, Young LS. 2009. Role of the Epstein-Barr virus-encoded latent membrane protein-1, LMP1, in the pathogenesis of nasopharyngeal carcinoma. Future Oncol 5:811-825. http://dx.doi.org/10.2217/fon.09.53.
-
(2009)
Future Oncol
, vol.5
, pp. 811-825
-
-
Morris, M.A.1
Dawson, C.W.2
Young, L.S.3
-
46
-
-
28044453314
-
IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism
-
Netea MG, Azam T, Ferwerda G, Girardin SE, Walsh M, Park JS, Abraham E, Kim JM, Yoon DY, Dinarello CA, Kim SH. 2005. IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism. Proc Natl Acad Sci USA 102:16309-16314. http://dx.doi.org/10.1073/pnas.0508237102.
-
(2005)
Proc Natl Acad Sci USA
, vol.102
, pp. 16309-16314
-
-
Netea, M.G.1
Azam, T.2
Ferwerda, G.3
Girardin, S.E.4
Walsh, M.5
Park, J.S.6
Abraham, E.7
Kim, J.M.8
Yoon, D.Y.9
Dinarello, C.A.10
Kim, S.H.11
-
47
-
-
84882361893
-
Interleukin (IL)-32beta-mediated CCAAT/enhancerbinding protein alpha (C/EBPalpha) phosphorylation by protein kinase Cdelta (PKCdelta) abrogates the inhibitory effect of C/EBPalpha on IL-10 production
-
Kang JW, Park YS, Kim MS, Lee DH, Bak Y, Ham SY, Park SH, Hong JT, Yoon DY. 2013. Interleukin (IL)-32beta-mediated CCAAT/enhancerbinding protein alpha (C/EBPalpha) phosphorylation by protein kinase Cdelta (PKCdelta) abrogates the inhibitory effect of C/EBPalpha on IL-10 production. J Biol Chem 288:23650-23658. http://dx.doi.org/10.1074/jbc.M113.465575.
-
(2013)
J Biol Chem
, vol.288
, pp. 23650-23658
-
-
Kang, J.W.1
Park, Y.S.2
Kim, M.S.3
Lee, D.H.4
Bak, Y.5
Ham, S.Y.6
Park, S.H.7
Hong, J.T.8
Yoon, D.Y.9
-
48
-
-
0030747497
-
Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors
-
Eliopoulos AG, Stack M, Dawson CW, Kaye KM, Hodgkin L, Sihota S, Rowe M, Young LS. 1997. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors. Oncogene 14:2899-2916. http://dx.doi.org/10.1038/sj.onc.1201258.
-
(1997)
Oncogene
, vol.14
, pp. 2899-2916
-
-
Eliopoulos, A.G.1
Stack, M.2
Dawson, C.W.3
Kaye, K.M.4
Hodgkin, L.5
Sihota, S.6
Rowe, M.7
Young, L.S.8
-
49
-
-
0034781792
-
Induction of interleukin-8 by Epstein-Barr virus latent membrane protein-1 and its correlation to angiogenesis in nasopharyngeal carcinoma
-
Yoshizaki T, Horikawa T, Qing-Chun R, Wakisaka N, Takeshita H, Sheen TS, Lee SY, Sato H, Furukawa M. 2001. Induction of interleukin-8 by Epstein-Barr virus latent membrane protein-1 and its correlation to angiogenesis in nasopharyngeal carcinoma. Clin Cancer Res 7:1946-1951.
-
(2001)
Clin Cancer Res
, vol.7
, pp. 1946-1951
-
-
Yoshizaki, T.1
Horikawa, T.2
Qing-Chun, R.3
Wakisaka, N.4
Takeshita, H.5
Sheen, T.S.6
Lee, S.Y.7
Sato, H.8
Furukawa, M.9
-
50
-
-
40049106893
-
Latent membrane protein 1 of EBV activates phosphatidylinositol 3-kinase to induce production of IL-10
-
Lambert SL, Martinez OM. 2007. Latent membrane protein 1 of EBV activates phosphatidylinositol 3-kinase to induce production of IL-10. J Immunol 179:8225-8234. http://dx.doi.org/10.4049/jimmunol.179.12.8225.
-
(2007)
J Immunol
, vol.179
, pp. 8225-8234
-
-
Lambert, S.L.1
Martinez, O.M.2
-
51
-
-
0031550566
-
Binding of the ubiquitous cellular transcription factors Sp1 and Sp3 to the ZI domains in the Epstein-Barr virus lytic switch BZLF1 gene promoter
-
Liu S, Borras AM, Liu P, Suske G, Speck SH. 1997. Binding of the ubiquitous cellular transcription factors Sp1 and Sp3 to the ZI domains in the Epstein-Barr virus lytic switch BZLF1 gene promoter. Virology 228: 11-18. http://dx.doi.org/10.1006/viro.1996.8371.
-
(1997)
Virology
, vol.228
, pp. 11-18
-
-
Liu, S.1
Borras, A.M.2
Liu, P.3
Suske, G.4
Speck, S.H.5
-
52
-
-
0031016035
-
Cyclosporin A-sensitive induction of the Epstein-Barr virus lytic switch is mediated via a novel pathway involving a MEF2 family member
-
Liu S, Liu P, Borras A, Chatila T, Speck SH. 1997. Cyclosporin A-sensitive induction of the Epstein-Barr virus lytic switch is mediated via a novel pathway involving a MEF2 family member. EMBO J 16:143-153. http://dx.doi.org/10.1093/emboj/16.1.143.
-
(1997)
EMBO J
, vol.16
, pp. 143-153
-
-
Liu, S.1
Liu, P.2
Borras, A.3
Chatila, T.4
Speck, S.H.5
-
53
-
-
0030760456
-
Reactivation of Epstein-Barr virus: regulation and function of the BZLF1 gene
-
Speck SH, Chatila T, Flemington E. 1997. Reactivation of Epstein-Barr virus: regulation and function of the BZLF1 gene. Trends Microbiol 5:399-405. http://dx.doi.org/10.1016/S0966-842X(97)01129-3.
-
(1997)
Trends Microbiol
, vol.5
, pp. 399-405
-
-
Speck, S.H.1
Chatila, T.2
Flemington, E.3
-
54
-
-
45549096221
-
Essential role of PKCdelta in histone deacetylase inhibitorinduced Epstein-Barr virus reactivation in nasopharyngeal carcinoma cells
-
Lee HH, Chang SS, Lin SJ, Chua HH, Tsai TJ, Tsai K, Lo YC, Chen HC, Tsai CH. 2008. Essential role of PKCdelta in histone deacetylase inhibitorinduced Epstein-Barr virus reactivation in nasopharyngeal carcinoma cells. J Gen Virol 89:878-883. http://dx.doi.org/10.1099/vir.0.83533-0.
-
(2008)
J Gen Virol
, vol.89
, pp. 878-883
-
-
Lee, H.H.1
Chang, S.S.2
Lin, S.J.3
Chua, H.H.4
Tsai, T.J.5
Tsai, K.6
Lo, Y.C.7
Chen, H.C.8
Tsai, C.H.9
-
55
-
-
0036855827
-
Activation mechanisms of protein kinase C: maturation, catalytic activation, and targeting
-
Shirai Y, Saito N. 2002. Activation mechanisms of protein kinase C: maturation, catalytic activation, and targeting. J Biochem 132:663-668. http://dx.doi.org/10.1093/oxfordjournals.jbchem.a003271.
-
(2002)
J Biochem
, vol.132
, pp. 663-668
-
-
Shirai, Y.1
Saito, N.2
-
56
-
-
10944238407
-
Distinctive activation mechanisms and functions for protein kinase Cdelta
-
Steinberg SF. 2004. Distinctive activation mechanisms and functions for protein kinase Cdelta. Biochem J 384:449-459. http://dx.doi.org/10.1042/BJ20040704.
-
(2004)
Biochem J
, vol.384
, pp. 449-459
-
-
Steinberg, S.F.1
-
57
-
-
34548861463
-
Biochemical assays for multiple activation states of protein kinase C
-
Yamamoto T, Matsuzaki H, Kamada S, Ono Y, Kikkawa U. 2007. Biochemical assays for multiple activation states of protein kinase C. Nat Protoc 1:2791-2795. http://dx.doi.org/10.1038/nprot.2006.420.
-
(2007)
Nat Protoc
, vol.1
, pp. 2791-2795
-
-
Yamamoto, T.1
Matsuzaki, H.2
Kamada, S.3
Ono, Y.4
Kikkawa, U.5
-
58
-
-
41149092838
-
Epstein-Barr virus: a paradigm for persistent infection-for real and in virtual reality
-
Thorley-Lawson DA, Duca KA, Shapiro M. 2008. Epstein-Barr virus: a paradigm for persistent infection-for real and in virtual reality. Trends Immunol 29:195-201. http://dx.doi.org/10.1016/j.it.2008.01.006.
-
(2008)
Trends Immunol
, vol.29
, pp. 195-201
-
-
Thorley-Lawson, D.A.1
Duca, K.A.2
Shapiro, M.3
-
59
-
-
42449106924
-
Kaposi's sarcoma-associated herpesvirus latent gene vFLIP inhibits viral lytic replication through NF-kappaB-mediated suppression of the AP-1 pathway: a novel mechanism of virus control of latency
-
Ye FC, Zhou FC, Xie JP, Kang T, Greene W, Kuhne K, Lei XF, Li QH, Gao SJ. 2008. Kaposi's sarcoma-associated herpesvirus latent gene vFLIP inhibits viral lytic replication through NF-kappaB-mediated suppression of the AP-1 pathway: a novel mechanism of virus control of latency. J Virol 82:4235-4249. http://dx.doi.org/10.1128/JVI.02370-07.
-
(2008)
J Virol
, vol.82
, pp. 4235-4249
-
-
Ye, F.C.1
Zhou, F.C.2
Xie, J.P.3
Kang, T.4
Greene, W.5
Kuhne, K.6
Lei, X.F.7
Li, Q.H.8
Gao, S.J.9
-
60
-
-
0037039363
-
Control of Epstein-Barr virus reactivation by activated CD40 and viral latent membrane protein 1
-
Adler B, Schaadt E, Kempkes B, Zimber-Strobl U, Baier B, Bornkamm GW. 2002. Control of Epstein-Barr virus reactivation by activated CD40 and viral latent membrane protein 1. Proc Natl Acad Sci U S A 99:437-442. http://dx.doi.org/10.1073/pnas.221439999.
-
(2002)
Proc Natl Acad Sci U S A
, vol.99
, pp. 437-442
-
-
Adler, B.1
Schaadt, E.2
Kempkes, B.3
Zimber-Strobl, U.4
Baier, B.5
Bornkamm, G.W.6
-
61
-
-
0037385685
-
Latent membrane protein 1 inhibits Epstein-Barr virus lytic cycle induction and progress via different mechanisms
-
Prince S, Keating S, Fielding C, Brennan P, Floettmann E, Rowe M. 2003. Latent membrane protein 1 inhibits Epstein-Barr virus lytic cycle induction and progress via different mechanisms. J Virol 77:5000-5007. http://dx.doi.org/10.1128/JVI.77.8.5000-5007.2003.
-
(2003)
J Virol
, vol.77
, pp. 5000-5007
-
-
Prince, S.1
Keating, S.2
Fielding, C.3
Brennan, P.4
Floettmann, E.5
Rowe, M.6
-
62
-
-
44849104379
-
Activation of interleukin-32 pro-inflammatory pathway in response to influenza A virus infection
-
Li W, Liu Y, Mukhtar MM, Gong R, Pan Y, Rasool ST, Gao Y, Kang L, Hao Q, Peng G, Chen Y, Chen X, Wu J, Zhu Y. 2008. Activation of interleukin-32 pro-inflammatory pathway in response to influenza A virus infection. PLoS One 3:e1985. http://dx.doi.org/10.1371/journal.pone.0001985.
-
(2008)
PLoS One
, vol.3
-
-
Li, W.1
Liu, Y.2
Mukhtar, M.M.3
Gong, R.4
Pan, Y.5
Rasool, S.T.6
Gao, Y.7
Kang, L.8
Hao, Q.9
Peng, G.10
Chen, Y.11
Chen, X.12
Wu, J.13
Zhu, Y.14
-
63
-
-
79251627826
-
Activation of the interleukin-32 proinflammatory pathway in response to human papillomavirus infection and over-expression of interleukin-32 controls the expression of the human papillomavirus oncogene
-
Lee S, Kim JH, Kim H, Kang JW, Kim SH, Yang Y, Kim J, Park J, Park S, Hong J, Yoon DY. 2011. Activation of the interleukin-32 proinflammatory pathway in response to human papillomavirus infection and over-expression of interleukin-32 controls the expression of the human papillomavirus oncogene. Immunology 132:410-420. http://dx.doi.org/10.1111/j.1365-2567.2010.03377.x.
-
(2011)
Immunology
, vol.132
, pp. 410-420
-
-
Lee, S.1
Kim, J.H.2
Kim, H.3
Kang, J.W.4
Kim, S.H.5
Yang, Y.6
Kim, J.7
Park, J.8
Park, S.9
Hong, J.10
Yoon, D.Y.11
-
64
-
-
79957821839
-
Interleukin-32 expression induced by hepatitis B virus protein X is mediated through activation of NF-kappaB
-
Pan X, Cao H, Lu J, Shu X, Xiong X, Hong X, Xu Q, Zhu H, Li G, Shen G. 2011. Interleukin-32 expression induced by hepatitis B virus protein X is mediated through activation of NF-kappaB. Mol Immunol 48:1573-1577. http://dx.doi.org/10.1016/j.molimm.2011.03.012.
-
(2011)
Mol Immunol
, vol.48
, pp. 1573-1577
-
-
Pan, X.1
Cao, H.2
Lu, J.3
Shu, X.4
Xiong, X.5
Hong, X.6
Xu, Q.7
Zhu, H.8
Li, G.9
Shen, G.10
-
65
-
-
80052073170
-
Canonical NF-kappaB activation is essential for Epstein-Barr virus latent membrane protein 1 TES2/CTAR2 gene regulation
-
Gewurz BE, Mar JC, Padi M, Zhao B, Shinners NP, Takasaki K, Bedoya E, Zou JY, Cahir-McFarland E, Quackenbush J, Kieff E. 2011. Canonical NF-kappaB activation is essential for Epstein-Barr virus latent membrane protein 1 TES2/CTAR2 gene regulation. J Virol 85:6764-6773. http://dx.doi.org/10.1128/JVI.00422-11.
-
(2011)
J Virol
, vol.85
, pp. 6764-6773
-
-
Gewurz, B.E.1
Mar, J.C.2
Padi, M.3
Zhao, B.4
Shinners, N.P.5
Takasaki, K.6
Bedoya, E.7
Zou, J.Y.8
Cahir-McFarland, E.9
Quackenbush, J.10
Kieff, E.11
-
66
-
-
0037770173
-
NFkappaB inhibits gammaherpesvirus lytic replication
-
Brown HJ, Song MJ, Deng H, Wu TT, Cheng G, Sun R. 2003. NFkappaB inhibits gammaherpesvirus lytic replication. J Virol 77:8532-8540. http://dx.doi.org/10.1128/JVI.77.15.8532-8540.2003.
-
(2003)
J Virol
, vol.77
, pp. 8532-8540
-
-
Brown, H.J.1
Song, M.J.2
Deng, H.3
Wu, T.T.4
Cheng, G.5
Sun, R.6
-
67
-
-
84858153678
-
Dysregulation of overexpressed IL-32alpha in hepatocellular carcinoma suppresses cell growth and induces apoptosis through inactivation of NF-kappaB and Bcl-2
-
Kang YH, Park MY, Yoon DY, Han SR, Lee CI, Ji NY, Myung PK, Lee HG, Kim JW, Yeom YI, Jang YJ, Ahn DK, Song EY. 2012. Dysregulation of overexpressed IL-32alpha in hepatocellular carcinoma suppresses cell growth and induces apoptosis through inactivation of NF-kappaB and Bcl-2. Cancer Lett 318:226-233. http://dx.doi.org/10.1016/j.canlet.2011.12.023.
-
(2012)
Cancer Lett
, vol.318
, pp. 226-233
-
-
Kang, Y.H.1
Park, M.Y.2
Yoon, D.Y.3
Han, S.R.4
Lee, C.I.5
Ji, N.Y.6
Myung, P.K.7
Lee, H.G.8
Kim, J.W.9
Yeom, Y.I.10
Jang, Y.J.11
Ahn, D.K.12
Song, E.Y.13
-
68
-
-
77950369161
-
IL-32 is expressed by human primary keratinocytes and modulates keratinocyte apoptosis in atopic dermatitis
-
Meyer N, Zimmermann M, Burgler S, Bassin C, Woehrl S, Moritz K, Rhyner C, Indermitte P, Schmid-Grendelmeier P, Akdis M, Menz G, Akdis CA. 2010. IL-32 is expressed by human primary keratinocytes and modulates keratinocyte apoptosis in atopic dermatitis. J Allergy Clin Immunol 125:858-865.e810. http://dx.doi.org/10.1016/j.jaci.2010.01.016.
-
(2010)
J Allergy Clin Immunol
, vol.125
, pp. 858-865
-
-
Meyer, N.1
Zimmermann, M.2
Burgler, S.3
Bassin, C.4
Woehrl, S.5
Moritz, K.6
Rhyner, C.7
Indermitte, P.8
Schmid-Grendelmeier, P.9
Akdis, M.10
Menz, G.11
Akdis, C.A.12
|